Extracellular nicotinamide phosphoribosyltransferase (NAMPT/visfatin) inhibits insulin-like growth factor-1 signaling and proteoglycan synthesis in human articular chondrocytes
Open Access
- 30 January 2012
- journal article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 14 (1) , R23
Abstract
Introduction: Obesity is one of the major risk factors for the development of osteoarthritis (OA). Although the mechanical factors appear to be critical, recent studies have suggested a role for adipokines in cartilage degradation. Chondrocytes from osteoarthritic cartilage respond poorly to insulin-like growth factor-1 (IGF-1) and the molecular mechanism(s) involved is not clearly understood. The purpose of the present study was to determine the role of extracellular nicotinamide phosphoribosyltransferase (eNAMPT/visfatin), a newly described adipokine, in regulating IGF-1 function in chondrocytes. Methods: Human articular chondrocytes isolated from normal ankle cartilage were pretreated with eNAMPT (0.1 to 5.0 μg/ml) overnight followed by stimulation with IGF-1 (50 ng/ml) for 24 hours, and proteoglycan synthesis was measured by [35S]sulfate incorporation. Chondrocytes were pretreated with eNAMPT overnight followed by IGF-1 for 10 minutes, and the cell lysates were immunoblotted for various signaling proteins that are activated by IGF-1 using phosphospecific antibodies. In addition, chondrocytes were pretreated with mitogen-activated protein kinase kinase inhibitor (U0126) prior to stimulation with eNAMPT and IGF-1. Results: Pretreatment of chondrocytes with eNAMPT inhibited IGF-1-stimulated proteoglycan synthesis in a dose-dependent manner. Treatment of chondrocytes with eNAMPT inhibited IGF-1-induced phosphorylation of signaling molecules, including insulin receptor substrate-1 and AKT. Interestingly, pretreatment of chondrocytes with eNAMPT did not inhibit IGF-1-mediated phosphorylation of the IGF-1 receptor; however, it stimulated a sustained phosphorylation of the extracellular signal-regulated kinase (ERK)/mitogen activated protein kinase (MAPK) signaling pathway. Inhibition of the ERK/MAPK signaling pathway restored IGF-1-mediated insulin receptor substrate-1 and AKT phosphorylation. Conclusions: Our study demonstrates that eNAMPT/visfatin inhibits IGF-1 function in articular chondrocytes by activating the ERK/MAPK pathway independent of the IGF-1 receptor. Since eNAMPT levels are elevated in the synovial fluid of OA patients, the signaling pathway activated by eNAMPT could contribute to IGF-1 resistance in OA.Keywords
This publication has 32 references indexed in Scilit:
- Increased synovial fluid visfatin is positively linked to cartilage degradation biomarkers in osteoarthritisRheumatology International, 2011
- Nampt: linking NAD biology, metabolism and cancerTrends in Endocrinology & Metabolism, 2009
- Serine Phosphorylation Proximal to Its Phosphotyrosine Binding Domain Inhibits Insulin Receptor Substrate 1 Function and Promotes Insulin ResistanceMolecular and Cellular Biology, 2004
- Growth phase‐dependent changes in the subcellular localization of pre‐B‐cell colony‐enhancing factor1FEBS Letters, 2003
- Phosphorylation of Ser307 in Insulin Receptor Substrate-1 Blocks Interactions with the Insulin Receptor and Inhibits Insulin ActionJournal of Biological Chemistry, 2002
- Reduction in the chondrocyte response to insulin‐like growth factor 1 in aging and osteoarthritis: Studies in a non‐human primate model of naturally occurring diseaseArthritis & Rheumatism, 2000
- Prevalence of degenerative morphological changes in the joints of the lower extremityOsteoarthritis and Cartilage, 1997
- Insulin-Like Growth Factors and Their Binding Proteins: Biological Actions*Endocrine Reviews, 1995
- Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor.Molecular and Cellular Biology, 1994
- The relationship of obesity, fat distribution and osteoarthritis in women in the general population: the Chingford Study.1993